Recent studies propose as a target for colorectal cancer EGFR (overexpressed in 60–80% of aggressive tumors) or CAE as chimeric antigen receptors allow T-cells to recognize tumor cells and quickly destroy them [70]. The gene discussed is EGFR; the disease is neoplasm.